<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01140490</url>
  </required_header>
  <id_info>
    <org_study_id>8020</org_study_id>
    <nct_id>NCT01140490</nct_id>
  </id_info>
  <brief_title>Sub-total Parathyroidectomy Reduces Vascular Calcification in Haemodialysis Patients</brief_title>
  <official_title>Sub-total Parathyroidectomy Reduces Vascular Calcification in Haemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate whether successful sub-total parathyroidectomy retards
      cardiovascular calcification in patients with hemodialysis and to investigate the mechanism .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperparathyroidism (PHPT) in patients with end-stage renal disease have been shown to have
      an increased morbidity and mortality mainly due to cardiovascular disease. The precise
      mechanism of cardiovascular disease in PHPT is not well understood . The excess in
      cardiovascular mortality is significantly and independently related to serum calcium, the
      connection between the biochemical disturbances and the cardiovascular disorders in PHPT
      patients is not necessarily a cause-and-effect relationship. Indeed, the impact of surgical
      cure of hyperparathyroidism on cardiovascular risk factors and mortality is controversial.
      Some studies suggest that cardiovascular risk markers remained unaltered after Sub-total
      Parathyroidectomy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in vascular calcium scores</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in left ventricular systolic and diastolic function</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Sub-total Parathyroidectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sub-total Parathyroidectomy</intervention_name>
    <description>Sub-total Parathyroidectomy</description>
    <arm_group_label>Sub-total Parathyroidectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients receiving hemodialysis treatment, with elevated intact parathyroid
             hormone (iPTH) levels &gt; 800pg/ml on two or more occasions.

          -  Patients with parathyroid nodular or diffuse hyperplasia identified by ultrasound
             imaging or radioisotope scan.

        Exclusion Criteria:

          -  Patients with significant background valvular heart disease

          -  Patients who are unfit for general anaesthesia

          -  Patients with acute myocardial infarction within recent two months

          -  Patients with poor general condition

          -  Patients with plans for living related kidney transplant within 1 year

          -  Patients with previous history of parathyroidectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shi wei, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Nephrology Committee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shi Wei, MD and PHD</last_name>
    <phone>8602083827812</phone>
    <phone_ext>62027</phone_ext>
    <email>shiw_ggh@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liu shuangxin, MD and PHD</last_name>
    <phone>8602083827812</phone>
    <phone_ext>62027</phone_ext>
    <email>mplsxi@yahoo.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu shuangxin, MD and Phd</last_name>
      <phone>8602083827812</phone>
      <phone_ext>62027</phone_ext>
      <email>mplsxi@yahoo.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2010</study_first_submitted>
  <study_first_submitted_qc>June 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2010</study_first_posted>
  <last_update_submitted>March 10, 2011</last_update_submitted>
  <last_update_submitted_qc>March 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Guangdong General Hospital</name_title>
    <organization>Department of nephrology</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Sub-total Parathyroidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
    <mesh_term>Vascular Calcification</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

